A random urine test panel aids in diagnosing mast cell activation syndrome (MCAS), a complex condition often misdiagnosed due to overlapping symptoms. The panel improves access, speeds up diagnosis, and enables individualized treatment by detecting key mast cell mediators.

At this year's Classical Hematology Conference we will be joined by Hematology experts, Adam Cuker, M.D. and Stephan Moll, M.D. Reserve your spot today.

William Morice II, M.D., Ph.D., highlights data-driven reasons health systems benefit from the lab service line and strategies to bolster performance.

Results of a new study by researchers at Mayo Clinic and Washington State University show that hydrogen peroxide-producing e-bandages may be an effective alternative to antibiotics for managing infected wounds.  

Topic highlights include: Mayo Clinic platform leader Dr. John Halamka turning 'healthcare data into wisdom', Loss of smell, taste no longer predominant COVID symptoms as virus continues to mutate, UK study: Don’t ruin your cookout by serving E. coli.

In this episode, Dr. Pritt and Dr. Morice discuss the science behind the increasing COVID-19 infections, why individuals can get reinfected with different variants, and the effectiveness of the at-home antigen tests.

Working with Mayo Clinic BioPharma Diagnostics clients, Grant Elmquist is engaged in a wide range of activities that span research and science technology, as well as a host of disease states, all with the end goal of enhancing patient care.

This week's research roundup features: Structural Cardiac Abnormalities in Patients with Atrial Fibrillation-Flutter and Myocardial Injury.

Mayo Clinic neuropathologist Caterina Giannini, M.D., Ph.D., received the American Association of Neuropathologists’ (AANP) award for Meritorious Contributions to Neuropathology during the AANP’s 98th annual meeting in June.

Topic highlights include: FDA to Authorize Novavax’s Covid-19 Vaccine, Newsom Announces California Will Produce Its Own ‘Low Cost’ Insulin, New dominant COVID-19 variant most transmissible yet, health officials say.

In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., sits down with Joseph Maleszewski, M.D., professor of Laboratory Medicine and Pathology and consultant in Anatomic Pathology at Mayo Clinic, to discuss the trending topic of 3D imaging technology.

William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with podcast host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice discuss advances in monkeypox testing, working with the CDC to scale testing and response efforts, the fast-spreading BA.5 variant of COVID-19, and how at-home testing affects the number of reported cases.

Diagnostic tests are a critical part of America’s health infrastructure and helping people live healthier lives. But in a recent op-ed published on RealClearPolicy, William Morice II, M.D., president of Mayo Clinic Laboratories and Matt Sause, president and CEO of Roche Diagnostics North America, explain how the well-intended Protecting Access to Medicare Act of 2014 (PAMA) puts vital diagnostic tests at risk.

Bringing together advanced testing technology, unparalleled expertise, and a patient-focused approach, Mayo Clinic Laboratories’ new high-resolution urine drug testing profile, ADMPU, evaluates for 22 drug classes including alcohol, marijuana, and nicotine, enabling clarity on substance use and precision insights that propel treatment.

This week's research roundup features: PFKFB3 works on the FAK-STAT3-SOX2 axis to regulate the stemness in MPM.